A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime

ABSTRACT This study sought to define the transit of cefepime between plasma and cerebral spinal fluid (CSF) in a rat model. Male Sprague-Dawley rats received cefepime intravenously. A total daily dose of 150 mg/kg of body weight/day was administered as a single injection every 24 h for 4 days. Plasm...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sean N. Avedissian, Gwendolyn Pais, Medha D. Joshi, Nathaniel J. Rhodes, Marc H. Scheetz
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2019
Materias:	cefepime cerebral spinal fluid pharmacokinetics Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/e369e04b7fa54d42997725c197c9cb6e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e369e04b7fa54d42997725c197c9cb6e
record_format	dspace
spelling	oai:doaj.org-article:e369e04b7fa54d42997725c197c9cb6e2021-11-15T15:22:04ZA Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime10.1128/mSphere.00595-182379-5042https://doaj.org/article/e369e04b7fa54d42997725c197c9cb6e2019-02-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSphere.00595-18https://doaj.org/toc/2379-5042ABSTRACT This study sought to define the transit of cefepime between plasma and cerebral spinal fluid (CSF) in a rat model. Male Sprague-Dawley rats received cefepime intravenously. A total daily dose of 150 mg/kg of body weight/day was administered as a single injection every 24 h for 4 days. Plasma samples were obtained via a second dedicated intravenous catheter. CSF sampling occurred via an intracisternal catheter. Cefepime levels in plasma and CSF were quantified via liquid chromatography-tandem mass spectrometry (LC-MS/MS). Pharmacokinetic (PK) analyses were conducted using Pmetrics for R. PK parameters and exposures during the first 24 h (i.e., area under the concentration-time curve from 0 to 24 h [AUC0–24] and maximum concentration of drug in serum from 0 to 24 h [Cmax 0–24]) were calculated from Bayesian posteriors. CSF penetration was estimated by comparing the exposure profiles between plasma and the CSF. Eleven rats contributed PK data. A four-compartmental model with a lag compartment for CSF fit the data well for both plasma (Bayesian [R2 = 0.956]) and CSF (Bayesian [R2 = 0.565]). Median parameter values (with the coefficient of variation percentage [CV%] in parentheses) for the rate constants to CSF from the lag compartment (K34), to the central compartment from the CSF compartment (K41), and to the lag compartment from the central compartment (K13) were 2.96 h−1 (116.27%), 0.47 h−1 (54.86%), and 0.13 h−1 (23.42%), respectively. The elimination rate constant (kel) was 3.15 h−1 (7.5%). Exposure estimation revealed a plasma median (with interquartile range [IQR] in parentheses) half-life, AUC0–24, and Cmax 0–24, of 1.7 (1.5 to 1.9) h, 111.3 (95.7 to 136.5) mg · 24 h/liter, and 177.8 (169.7 to 236.4) μg/ml, from the first dose, respectively. Exposure estimation of CSF demonstrated a median (with IQR in parentheses) AUC0–24 and Cmax 0–24 of 26.3 (16.6 to 43.1) mg · 24 h/liter and 6.8 (5.2 to 9.4) μg/ml, respectively. The median CSF/blood percentage of penetration was 19%. Cefepime transit to the CSF is rapid and predictable in the rat model. This model will be highly useful for understanding the therapeutic window for cefepime and neurotoxicity. IMPORTANCE This study defines the transit of cefepime between plasma and cerebral spinal fluid (CSF) in a rat model. Male Sprague-Dawley rats received cefepime intravenously. Plasma samples were obtained via a second dedicated intravenous catheter. CSF sampling occurred via an intracisternal catheter. Drug exposures and transfer from the plasma to the CSF during the first 24 h were calculated. The median CSF/blood percentage of penetration was 19%. Cefepime transit to the CSF is rapid and predictable in the rat model. This model will be highly useful for understanding the therapeutic window for cefepime and neurotoxicity.Sean N. AvedissianGwendolyn PaisMedha D. JoshiNathaniel J. RhodesMarc H. ScheetzAmerican Society for Microbiologyarticlecefepimecerebral spinal fluidpharmacokineticsMicrobiologyQR1-502ENmSphere, Vol 4, Iss 1 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	cefepime cerebral spinal fluid pharmacokinetics Microbiology QR1-502
spellingShingle	cefepime cerebral spinal fluid pharmacokinetics Microbiology QR1-502 Sean N. Avedissian Gwendolyn Pais Medha D. Joshi Nathaniel J. Rhodes Marc H. Scheetz A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime
description	ABSTRACT This study sought to define the transit of cefepime between plasma and cerebral spinal fluid (CSF) in a rat model. Male Sprague-Dawley rats received cefepime intravenously. A total daily dose of 150 mg/kg of body weight/day was administered as a single injection every 24 h for 4 days. Plasma samples were obtained via a second dedicated intravenous catheter. CSF sampling occurred via an intracisternal catheter. Cefepime levels in plasma and CSF were quantified via liquid chromatography-tandem mass spectrometry (LC-MS/MS). Pharmacokinetic (PK) analyses were conducted using Pmetrics for R. PK parameters and exposures during the first 24 h (i.e., area under the concentration-time curve from 0 to 24 h [AUC0–24] and maximum concentration of drug in serum from 0 to 24 h [Cmax 0–24]) were calculated from Bayesian posteriors. CSF penetration was estimated by comparing the exposure profiles between plasma and the CSF. Eleven rats contributed PK data. A four-compartmental model with a lag compartment for CSF fit the data well for both plasma (Bayesian [R2 = 0.956]) and CSF (Bayesian [R2 = 0.565]). Median parameter values (with the coefficient of variation percentage [CV%] in parentheses) for the rate constants to CSF from the lag compartment (K34), to the central compartment from the CSF compartment (K41), and to the lag compartment from the central compartment (K13) were 2.96 h−1 (116.27%), 0.47 h−1 (54.86%), and 0.13 h−1 (23.42%), respectively. The elimination rate constant (kel) was 3.15 h−1 (7.5%). Exposure estimation revealed a plasma median (with interquartile range [IQR] in parentheses) half-life, AUC0–24, and Cmax 0–24, of 1.7 (1.5 to 1.9) h, 111.3 (95.7 to 136.5) mg · 24 h/liter, and 177.8 (169.7 to 236.4) μg/ml, from the first dose, respectively. Exposure estimation of CSF demonstrated a median (with IQR in parentheses) AUC0–24 and Cmax 0–24 of 26.3 (16.6 to 43.1) mg · 24 h/liter and 6.8 (5.2 to 9.4) μg/ml, respectively. The median CSF/blood percentage of penetration was 19%. Cefepime transit to the CSF is rapid and predictable in the rat model. This model will be highly useful for understanding the therapeutic window for cefepime and neurotoxicity. IMPORTANCE This study defines the transit of cefepime between plasma and cerebral spinal fluid (CSF) in a rat model. Male Sprague-Dawley rats received cefepime intravenously. Plasma samples were obtained via a second dedicated intravenous catheter. CSF sampling occurred via an intracisternal catheter. Drug exposures and transfer from the plasma to the CSF during the first 24 h were calculated. The median CSF/blood percentage of penetration was 19%. Cefepime transit to the CSF is rapid and predictable in the rat model. This model will be highly useful for understanding the therapeutic window for cefepime and neurotoxicity.
format	article
author	Sean N. Avedissian Gwendolyn Pais Medha D. Joshi Nathaniel J. Rhodes Marc H. Scheetz
author_facet	Sean N. Avedissian Gwendolyn Pais Medha D. Joshi Nathaniel J. Rhodes Marc H. Scheetz
author_sort	Sean N. Avedissian
title	A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime
title_short	A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime
title_full	A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime
title_fullStr	A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime
title_full_unstemmed	A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime
title_sort	translational pharmacokinetic rat model of cerebral spinal fluid and plasma concentrations of cefepime
publisher	American Society for Microbiology
publishDate	2019
url	https://doaj.org/article/e369e04b7fa54d42997725c197c9cb6e
work_keys_str_mv	AT seannavedissian atranslationalpharmacokineticratmodelofcerebralspinalfluidandplasmaconcentrationsofcefepime AT gwendolynpais atranslationalpharmacokineticratmodelofcerebralspinalfluidandplasmaconcentrationsofcefepime AT medhadjoshi atranslationalpharmacokineticratmodelofcerebralspinalfluidandplasmaconcentrationsofcefepime AT nathanieljrhodes atranslationalpharmacokineticratmodelofcerebralspinalfluidandplasmaconcentrationsofcefepime AT marchscheetz atranslationalpharmacokineticratmodelofcerebralspinalfluidandplasmaconcentrationsofcefepime AT seannavedissian translationalpharmacokineticratmodelofcerebralspinalfluidandplasmaconcentrationsofcefepime AT gwendolynpais translationalpharmacokineticratmodelofcerebralspinalfluidandplasmaconcentrationsofcefepime AT medhadjoshi translationalpharmacokineticratmodelofcerebralspinalfluidandplasmaconcentrationsofcefepime AT nathanieljrhodes translationalpharmacokineticratmodelofcerebralspinalfluidandplasmaconcentrationsofcefepime AT marchscheetz translationalpharmacokineticratmodelofcerebralspinalfluidandplasmaconcentrationsofcefepime
_version_	1718428101589860352

A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime

Ejemplares similares